High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 11, 2001, Pages 1274-1281

  Ishikawa, Toru ^a   Ichida, Takafumi ^a   Yamagiwa, Satoshi ^a   Sugahara, Satoshi ^a   Uehara, Kazuhiro ^a   Okoshi, Shogo ^a   Asakura, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Confidence interval; Cox proportional hazard model; Hazard risk; Kaplan Meier method; Multivariate analysis

Indexed keywords

LACTATE DEHYDROGENASE; MEMBRANE ANTIGEN; VIRUS ANTIBODY; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; GENDER; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROBABILITY; REGRESSION ANALYSIS; RISK FACTOR; VIRUS INFECTION; VIRUS LOAD;

EID: 0035702543     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02616.x     Document Type: Article

References (34)

1. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis
2. Hepatocellular carcinoma. A worldwide problem and the major risk factors
3. Hepatocellular carcinoma
4. Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients
5. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis
6. Transection of the esophagus for bleeding esophageal varices
7. Quantitative detection of hepatitis virus transcription-mediated amplification and hybridization protection assay
8. A class of rank test procedures for censored survival data
9. Nonparametric estimation for incomplete observation
10. Regression models and life tables
11. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus. A pilot study
12. One year trial of lamivudine for chronic hepatitis B
13. A preliminary trial of lamivudine for chronic hepatitis B infection
14. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial
15. Lamivudine therapy for chronic hepatitis B: A six-month randomized doseranging study
16. Elevated serum testosterone levels and risk of hepatocellular carcinoma
17. A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis
18. Quantitation of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease
19. Risk factors the effect of interferon therapy in the development of hepatocellular carcinoma: A multivariate analysis in 343 patients
20. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis
21. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: Comparison in patients with hepatitiss B virus- and hepatitis C virus-associated cirrhosis
22. Hepatitis B and C viruses and their interaction in the origin of the hepatocellular carcinoma
23. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg
24. The hepatitis B virus persists for decades after patients recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response
25. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants
26. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan
27. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease
28. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States
29. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area
30. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis
31. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
32. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: Realtive risk and population attribute risk from a case-control study in Italy
33. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: A prospective study
34. Characteristics of patients with dual infection by hepatitis B and C viruses